These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9658611)

  • 1. Hepatitis B: long-term outcome and benefits from mass vaccination in children.
    Chang MH
    Acta Gastroenterol Belg; 1998; 61(2):210-3. PubMed ID: 9658611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for hepatitis B virus eradication and control of hepatocellular carcinoma.
    Chang MH; Chen DS
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Dec; 13(4):511-7. PubMed ID: 10654916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.
    Chien YC; Jan CF; Chiang CJ; Kuo HS; You SL; Chen CJ
    Hepatology; 2014 Jul; 60(1):125-32. PubMed ID: 24497203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched.
    Chien YC; Jan CF; Kuo HS; Chen CJ
    Epidemiol Rev; 2006; 28():126-35. PubMed ID: 16782778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic hepatitis B--still a problem in children].
    Pohaci-Antonesei L; Bratu L; Rusu T; Moraru E
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):738-42. PubMed ID: 21243800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trends were considered in the evaluation of universal hepatitis B vaccination in Taiwan.
    Chang CH; Lin JW; Tu YK
    J Clin Epidemiol; 2015 Apr; 68(4):405-11. PubMed ID: 25660961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus infection in children.
    Komatsu H; Inui A
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):427-50. PubMed ID: 25724218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination.
    Chen HL; Chang CJ; Kong MS; Huang FC; Lee HC; Lin CC; Liu CC; Lee IH; Wu TC; Wu SF; Ni YH; Hsu HY; Chen DS; Chang MH
    Hepatology; 2004 Jan; 39(1):58-63. PubMed ID: 14752823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program.
    McMahon BJ; Bulkow LR; Singleton RJ; Williams J; Snowball M; Homan C; Parkinson AJ
    Hepatology; 2011 Sep; 54(3):801-7. PubMed ID: 21618565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B.
    Haber BA; Block JM; Jonas MM; Karpen SJ; London WT; McMahon BJ; Murray KF; Narkewicz MR; Rosenthal P; Schwarz KB;
    Pediatrics; 2009 Nov; 124(5):e1007-13. PubMed ID: 19805457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan.
    Lin HH; Wang LY; Hu CT; Huang SC; Huang LC; Lin SS; Chiang YM; Liu TT; Chen CL
    J Med Virol; 2003 Apr; 69(4):471-4. PubMed ID: 12601753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization.
    Hsu HM; Lu CF; Lee SC; Lin SR; Chen DS
    J Infect Dis; 1999 Feb; 179(2):367-70. PubMed ID: 9878020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
    Thornley S; Bullen C; Roberts M
    J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Give all children vaccine against hepatitis B!].
    Weiland O
    Lakartidningen; 2001 Sep; 98(36):3780-4. PubMed ID: 11586807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
    Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
    Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.